Navigation Links
ATG useful in transplant patients as substitute for steroids

Anti-thymocyte globulin (ATG), a compound made from rabbit antibodies appears to be as effective as routine steroids in reducing rejection of transplanted organs without any of the side effects, according to Dr. James Eason of the Ochsner Multi-Organ Transplant Center in New Orleans. In the largest study on steroid-free treatment of liver transplants, Dr. Eason found patients treated with ATG had lower rejection and severity rates than patients who received standard steroid treatment. Also the acute rejection was 33% lesser in these patients.

Rejection was reversed in all patients who received rabbit ATG by increasing the anti-rejection drug alone, while 60 percent of patients in the steroid group required additional steroids for reversal. These findings were presented by Dr. Eason at Transplant 2001, the joint meeting of the American Society for Transplantation and the American Society of Transplant Surgeons.

Rabbit ATG is a purified, pasteurized, gamma immune globulin, obtained by immunization of rabbits with human thymocytes, which contains cytotoxic antibodies expressed on human T-lymphocytes. Steroids have been considered a key component of liver transplant treatment, even though they are associated with adverse side effects. When a patient receives an organ transplant, the body's white blood cells often try to reject the new organ .It is here that ATG steps in. The rabbit ATG works to prevent this from happening without the problems caused by steroids.

Unlike traditional long-term steroid treatment, normally used to reduce swelling and inflammation following organ transplant, Eason said patients receive rabbit ATG for just two days, the first dose during the transplant itself. The study found 4 percent of steroid-free patients developed post-transplant diabetes, compared to 14 percent in the steroid group, and only 50 percent of those receiving rabbit ATG developed recurrent hepatitis C or diabetes, compared to 70 percent of those on steroid treatment.

For those who are contemplating transplants but are worried about rejections and other steroid induced reactions these words of Dr. Eason will sound musical to their ears. But for a comprehensive analysis of ATG, one has to wait and watch the long-term effects. If it continues its good work, ATG will reduce the steroid related side effects and costs for patients, on life long immunosuppressive therapy to guard against transplant rejection, in a big way.
'"/>




Related medicine news :

1. Vitamin E useful for Alzheimers
2. Osteopontin: a useful biomarker in asbestos-related cancer
3. Carboplatin, Lung cancer drug may be useful in treating breast tumor
4. Infant receives first bloodless liver transplant
5. Liver donors can thrive after transplant
6. Stem cell transplantation of eye
7. Woman gets cancer from transplanted kidney
8. Parasite infections linked to organ transplants
9. Vitamins enhances recuperation of organ transplant patients
10. Vitamins suppress artery injury after transplant
11. Liver transplant oversight urged
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... 2017 , ... ARI Network Services, Inc. (NASDAQ: ARIS) announced today that Rhino ... its network of more than 650 U.S.-based dealers. Rhino, a member of the Alamo ... flail mowers and cutters, rear blades, post hole diggers, pasture renovators, tillers, disc mowers ...
(Date:3/29/2017)... ... ... Full Contact K9, an Atlanta-based dog services provider, has recently teamed up with ... in creating legally-enforceable pet trusts for their canine companions. , Therilus, a Harvard-trained ... new companion. Says Evan Dunbar, CEO of Full Contact K9, “When our clients purchase ...
(Date:3/29/2017)... ... March 30, 2017 , ... Youth Futures International (YFI) premiered ... feedback from high school and college students who have participated in the program every ... and YFI is now accepting applications for enrollment. Visit http://www.ghana.yfiexperience.org to ...
(Date:3/29/2017)... ... March 29, 2017 , ... Wells Pharmacy Network, a ... at the upcoming World Congress, in Hollywood Florida April 6-8, 2017. , Ben ... the visionary leader in the training of physicians, scientists, and members of the ...
(Date:3/29/2017)... Indianapolis, IN (PRWEB) , ... March 29, 2017 ... ... Benefits Study, this webinar provides insight into the challenges employers face in trying ... the complexity of managing employee benefits programs? Adding to the growing complexity, ...
Breaking Medicine News(10 mins):
(Date:3/30/2017)... DUBLIN , Mar 30, 2017 ... "Hemodialysis And Peritoneal Dialysis Market Size & Forecast, By Type ... (Home-based, Hospital-based), And Trend Analysis From 2014 To 2025" ... ... market is expected to reach USD 108.5 billion by 2025. ...
(Date:3/29/2017)... March 29, 2017 Wound care devices and ... of the wound. The industry mainly consists of establishments ... the treatment of wounds caused by mechanical, chemical, thermal, ... diseases such as diabetes, skin related diseases, immunological diseases, ... was the largest region in the wound ...
(Date:3/29/2017)... 2017 Avelas Biosciences, Inc., a clinical stage oncology-focused company ... announced that Carmine N. Stengone , president and chief executive ... & Company 16 th Annual Healthcare Conference on Wednesday, April ... Westin Grand Central Hotel in New York City ... ...
Breaking Medicine Technology: